ABSTRACT.
The rapid induction of IFN-γ by innate cytokines such as IL-12 and IL-18 is critical for immunity against infectious pathogens. We investigated the molecular mechanisms underlying this response. IL-12 and IL-18 rapidly and synergistically For personal use only. on . by guest www.bloodjournal.org From
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ABBREVIATIONS.
ARE, adenylate/uridylate-rich element; ATF2, activating transcription factor 2; COX-2, cyclooxygenase 2; GM-CSF, granulocyte/macrophage colony stimulating factor; HeLa-TO, Tetracyline Off HeLa cell line; IFN-γ, interferon-γ; IL, interleukin; MAPK, mitogen activated protein kinase; MK2, MAPK-activated protein kinase 2; MKK6, MAPK kinase 6; NFκB, nuclear factor kB; NK, natural killer; PBL, peripheral blood lymphocyte; STAT, signal transducer and activator of transcription; TNFα, tumor necrosis factor α; UTR, untranslated region.
For personal use only. on . by guest www.bloodjournal.org From
INTRODUCTION.
The production of IFN-γ is an early and critical event in the immune response to intracellular pathogens [1] [2] [3] [4] . A pleiotropic cytokine, IFN-γ influences both innate and acquired arms of the immune response 5, 6 . Firstly, it stimulates microbicidal activities of phagocytic cells, for example by activation of the respiratory burst. Secondly, it favours the development of a pro-inflammatory, cell-mediated immune response by stimulating antigen presentation and promoting the differentiation of Th1 lymphocytes. Mice that lack IFN-γ or its receptor display increased susceptibility to a number of pathogens 5, 6 . On the other hand, the overexpression or ectopic expression of IFN-γ causes a destructive, even lethal, inflammatory response 7, 8 . IFN-γ has also been implicated in autoimmune diseases such as insulin-dependent diabetes, multiple sclerosis and systemic lupus erythematosus 6 . Hence the tight regulation of IFN-γ gene expression is clearly of fundamental importance.
At early time points following infection, the expression of IFN-γ is principally detected in NK cells, later appearing in cytotoxic CD8+ memory T cells, then in Th1 CD4+ lymphocytes as the acquired immune response develops [9] [10] [11] [12] . The rapid production of IFN-γ by NK cells contributes to host defence prior to the emergence of an effective acquired immune response, or even in the absence of such a response 1, 13 .
Although NK cells may respond directly to some pathogens, in many cases the rapid expression of IFN-γ requires the mediation of professional antigen presenting cells 14 .
These sentinel cells deploy Toll-like receptors (TLRs) to detect the presence of pathogens, and respond by secreting a variety of cytokines, including IL-1β, IL-12, IL-15, IL-18 and TNFα. Although NK cells constitutively express receptors for both IL-12 and IL-18 15, 16 , either cytokine alone induces IFN-γ gene expression relatively [17] [18] [19] [20] [21] [22] .
Mitogen-activated protein kinase (MAPK) p38 is required for the induction of IFN-γ gene expression by a variety of agonists in T, NK and dendritic cells 17, [21] [22] [23] [24] [25] [26] [27] . Mice that lack MAPK-activated protein kinase 2 (MK2), a kinase activated by p38, are defective in expression of IFN-γ and consequently susceptible to the intracellular pathogen Listeria monocytogenes 28, 29 . MAPK p38 regulates the expression of several pro-inflammatory genes, including TNFα, IL-6, IL-8, GM-CSF and COX-2, by means of mRNA stabilization 28, 29 . This post-transcriptional regulation is mediated by MK2, and depends upon adenylate/uridylate rich elements (AREs), which are located within the 3' untranslated regions (UTRs) of p38-sensitive transcripts, and typically contain several copies of the pentameric motif AUUUA. Human IFN-γ mRNA contains five copies of the AUUUA motif within its 3' UTR, has a short half-life, and is post-transcriptionally regulated by IL-12 and other agonists [30] [31] [32] , although the mechanism has not been described. We hypothesized that the synergistic induction of IFN-γ protein by IL-12 and IL-18 in human NK cells involves the stabilization of IFN-γ mRNA by the MAPK p38 pathway. 33 .
ELISA.
IFN-γ levels in culture supernatants were measured using recombinant human IFN-γ and matched antibody pair sets (BD Biosciences) according to standard ELISA protocols. 96-well ELISA plates were read using a Labsystems Bichromatic plate reader, and IFN-γ protein concentrations were calculated using Ascent software (Dynex Labsystems, Ashford, UK).
Quantification of mRNA.
Total RNA was purified from lymphocytes using RNeasy mini kits (Qiagen, Crawley, UK), and assayed for cytokine mRNAs using the hCK-1 Riboquant Multiprobe RNase Protection Assay system according to manufacturer's instructions (BD Biosciences). For northern blotting, total RNA samples (10 µg) were subjected to electrophoresis on 1% formaldehyde-agarose gels, 28S rRNA was visualized by staining with SybrGreen (Molecular Probes, Leiden, The Netherlands) and quantified using a phosphorimager (Fuji FLA2000). Northern blotting was performed as described 35 , using an IFN-γ cDNA probe labelled using Ready-to-go reagents according to manufacturer's instructions (Amersham Biosciences, Chalfont St. Giles, UK). Measurement of β-globin and GAPDH mRNA in HeLa-TO cells was performed as described 33 . 
Western blotting.
Western blotting was performed as described 36 , using a rabbit polyclonal serum against p38 (gift of J. Saklatvala, Imperial College London, UK) or a phospho-p38-specific serum (Cell Signaling Technology, Hitchin, UK).
RESULTS.

IL-12 and IL-18 rapidly and synergistically induce IFN-γ mRNA and protein expression in a p38-dependent manner.
Preliminary experiments investigated the time-course of expression of IFN-γ mRNA and protein in response to IL-12 and IL-18 (data not shown). On this basis seven hours was selected as a convenient time point at which both mRNA and protein could consistently be detected. Peripheral blood lymphocytes (PBLs) were treated for 7h with IL-12 and IL-18, alone or in combination, in the absence or presence of the p38 inhibitor SB203580 (Fig 1a) . IL-12 alone consistently induced low levels of IFN-γ mRNA and protein (0.35 -3.25 ng/ml, n = 4), which were both reduced to background levels by 1 µM SB203580. Induction of IFN-γ gene expression by IL-18 alone was too weak for accurate measurement at this early time point. In combination IL-12 and IL-18 strongly induced expression of IFN-γ mRNA and protein, which were both inhibited by 1 µM SB203580. Although there was considerable donor variation in protein expression (3.5 -14.2 ng/ml, n = 12), the induction of protein and mRNA was consistently inhibited to a similar extent by 1 µM SB203580 (Fig 1b) .
The induction of IFN-γ mRNA by IL-12 and -18 was similarly inhibited by 1 µM SB203580 at earlier time points, whereas the induction of IFN-γ protein was similarly inhibited by 1 µM SB203580 if measured after 24h (data not shown). IFN-γ expression was significantly induced by stimulation with as little as 1 ng/ml IL-12 and IL-18, and was similarly inhibited by 1 µM SB203580 at all cytokine concentrations tested (data not shown). SB203580 inhibits the kinase activity of p38 with an IC 50 of approximately 0.6 µM, but can inhibit other kinases at higher concentrations. Fig 1c) . The induction of both IFN-γ mRNA and protein was inhibited significantly at 0.1 µM, >50% at 1 µM and almost completely at 10 µM SB203580, consistent with the drug's IC 50 for inhibition of p38. To determine which cells were involved in the response to IL-12 plus IL-18, PBLs were purified by centrifugal elutriation and analysed by flow cytometry (Fig 2a) . 6 -22% of PBLs were CD56+ CD3-(NK cells), whereas 2.5 -10% were CD56+ CD3+ (NKT cells). As expected CD56+ cells did not express CD4, however 30 -50% expressed the CD8 marker as previously reported 37 (data not shown 
SB203580 dose dependence was tested to confirm the involvement of p38 in IFN-γ
For personal use only. on November 16, 2017. by guest www.bloodjournal.org From For personal use only. on November 16, 2017. by guest www.bloodjournal.org From
MAPK p38 is activated by IL-12 and IL-18 in NK cells.
NK and T cells were purified by negative selection from peripheral blood and stimulated for 15 minutes with IL-12, IL-18 or arsenite, a reagent that activates p38 in most cell types. The activation of p38 was monitored by western blotting with an antibody specific for the phosphorylated (activated) kinase (Fig 3a) . Arsenite activated p38 in purified T cells, but neither cytokine did so, presumably reflecting the absence of functional receptors for these cytokines in naïve T cells. In contrast p38 was activated strongly by IL-18 and more weakly by IL-12 in purified NK cells.
To confirm this finding, flow cytometry was employed to monitor p38 phosphorylation i n purified NK cells, using a PE-conjugated antibody against phosphorylated p38. This antibody showed increased staining of arsenite-stimulated NK cells, whereas an isotype matched control antibody showed no equivalent increase (Fig 3b) . Furthermore, staining of arsenite-stimulated NK cells was blocked by a p38 phosphopeptide, but not by the equivalent unphosphorylated peptide, demonstrating the specificity of the phospho-p38 antibody (Fig 3b) . Flow cytometry confirmed that p38 was activated strongly by IL-18 and weakly by IL-12, with a slight additive effect in the presence of both cytokines (Fig 3c) . The latter effect was consistently detected by flow cytometry, but was too subtle to be observed by western blotting. The activation of p38 by IL-12 and -18 was prolonged, remaining detectable up to four hours after the stimulus (Fig 3c) . No activation of p38 by IL-12 or IL-18 was observed by flow cytometric analysis of purified T lymphocytes (data not shown).
Flow cytometry was used to investigate the relationship between p38 activation and IFN-γ gene expression (Fig 3d) . Intracellular IFN-γ could be detected two hours after 
IFN-γ mRNA is stabilized by MAPK p38.
The involvement of MAPK p38 in the regulation of IFN-γ mRNA stability was investigated by actinomycin D chase experiments. In peripheral blood lymphocytes stimulated with IL-12 and IL-18, IFN-γ mRNA was potently destabilized by 1 µM SB203580, its half life decreasing from 83 to 32 minutes (Fig 4a) . A similar destabilization of IFN-γ mRNA by 1 µM SB203580 occurred in purified, IL-12 + IL-18-treated NK cells (Fig 4b) .
A tetracycline-regulated post-transcriptional reporter system 34 was used to determine whether the IFN-γ 3' UTR mediates mRNA stabilization by the MAPK p38 pathway.
Briefly, a rabbit β-globin reporter mRNA is transcribed under the control of a tetracycline-regulated promoter in HeLa-TO cells, which stably express a tetracycline-repressible transcription factor. The reporter mRNA is allowed to accumulate for 24 hours, then its transcription is halted by the addition of tetracycline, and its subsequent decay is quantified by ribonuclease protection assay. The β-globin mRNA is stable and unresponsive to p38 activation or inhibition, however p38-responsive reporter mRNA decay is conferred by the insertion of 3' UTR elements derived from p38-regulated transcripts. Although IFN-γ gene expression is restricted to certain hematopoietic cells, the components of p38-regulated mRNA decay appear to be well conserved between cells. For example the p38-mediated stabilization of TNFα, GM-CSF and TTP mRNAs can be recapitulated in HeLa-TO cells that do not normally express these transcripts 35, 39, 40 . The HeLa-TO system can therefore be used as a convenient assay system to investigate cis-acting sequences and regulatory pathways involved in the control of IFN-γ mRNA stability. (Fig 5a) , in contrast to a β-globin reporter mRNA, which had a half-life in excess of four hours (data not shown). An active mutant of MKK6 was coexpressed with the reporter mRNA to activate the MAPK p38 pathway in transfected cells. This resulted in significant stabilization of the β-globin-IFN-γ reporter mRNA, which could be reversed by addition of 1 µM SB203580. The mechanism of regulation of β-globin-IFN-γ mRNA stability was investigated further by coexpression of constitutively active or dominant negative forms of MK2, the downstream kinase that mediates mRNA stabilization by p38. A constitutively active mutant of MK2 stabilized the reporter mRNA (Fig 5b) , whereas a dominant negative mutant inhibited the stabilization of reporter mRNA by MKK6 (Fig 5c) . Together, these data demonstrate that the IFN-γ 3' UTR mediates mRNA stabilization by the MKK6-p38-MK2 pathway.
For IL-18 shares some, though not all, signaling pathways with IL-1, and is capable of activating p38 47, 48 . We show that IL-18 activates p38 strongly in NK cells but not detectably in T lymphocytes. NK cells constitutively express the IL-18 receptor whereas naïve T cells do not 15, 16 . IL-12 upregulates the IL-18 receptor in T cells, providing a mechanism for synergy between the two cytokines 20, 49 . This mechanism is presumably too slow to drive significant T lymphocyte IFN-γ expression at the early time points investigated here. In NK cells MAPK p38 was also activated weakly by IL-12, consistent with the weak but p38-dependent induction of IFN-γ by this cytokine 50, 51 . In contrast to the strong, rapid and transient activation of p38 by IL-18, IL-12 induced a gradual increase in activity over an extended period (data not shown).
This suggests that the activation of p38 by IL-12 may be indirect, for example mediated by upregulation of GADD45-β or -γ, which can activate the p38 pathway 21, 52, 53 . This is currently under investigation.
Neither IL-18 nor IL-12 alone strongly induced IFN−γ gene expression, therefore the activation of p38 and stabilization of mRNA are insufficient, and transcriptional activation is likely to play a significant role in the synergistic induction of IFN-γ by the two cytokines. IL-12 induces transcription by means of tyrosine phosphorylation and activation of STAT4, a member of the signal-transducer-and-activator-oftranscription family [54] [55] [56] [57] , whilst IL-18 activates members of the NFκB and AP-1 families 47, 54, 58 . These different families of transcription factors can cooperate to induce IFN-γ expression 54, 55 . After 24 h, cells were treated with 1 µM SB203580 (SB) or vehicle (0.1% DMSO) for 5 min prior to addition of tetracycline (final concentration 100 ng/ml). Cells were harvested at the intervals shown, and ribonuclease protection assays performed to quantify β-globin-IFN-γ (reporter) and GAPDH (loading control) mRNAs. This experiment was performed three times, reporter mRNA levels were normalized against GAPDH, and mean outcomes plotted on a semi-logarithmic graph (lower panel). Error bars indicate SEM. B. HeLa-TO cells were transfected with 100 ng of pTetBBB-IFN-γ and 800 ng of pEF or pEF-MK2ca (which expresses a constitutively active mutant of MK2). Total DNA was made up to 1 µg by addition of carrier (pBluescript). After 24 h, tetracycline was added and cells were processed as above.
MAPK p38 may participate in transcriptional
